← Back to Search

Behavioural Intervention

Active lighting intervention then Control lighting condition for Alzheimer's Disease

N/A
Waitlist Available
Led By Mariana Figueiro, PhD
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 22 weeks
Awards & highlights

Study Summary

This trial is testing whether a special light intervention can improve sleep and mood in people with Alzheimer's disease.

Eligible Conditions
  • Alzheimer's Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 22 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 22 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sleep disturbance using the Pittsburgh Sleep Quality Index
Secondary outcome measures
Depression screening utilizing the Cornell Scale for Depression in Dementia (CSDD)
Sleep efficiency measured by actigraphy

Trial Design

2Treatment groups
Active Control
Group I: Active lighting intervention then Control lighting conditionActive Control2 Interventions
Each lighting condition will be 8 weeks in length. After a 4 week washout, each participant will crossover to the opposite condition.
Group II: Control lighting condition then Active light interventionActive Control2 Interventions
Each lighting condition will be 8 weeks in length. After a 4 week washout, each participant will crossover to the opposite condition.

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor
860 Previous Clinical Trials
524,462 Total Patients Enrolled
Mariana Figueiro, PhDPrincipal InvestigatorMount Sinai Icahn School of Medicine
9 Previous Clinical Trials
780 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still vacancies available in the research program?

"Indeed, the data on clinicaltrials.gov indicates that this trial is currently enlisting patients. The study was initially established on June 1st 2022 and further updated on August 25th of the same year. Thirty participants need to be enrolled from a single location for completion."

Answered by AI

How many participants are currently taking part in this clinical experiment?

"Affirmative. Per the information on clinicaltrials.gov, this medical investigation is actively recruiting volunteers - starting from its inception date of June 1st 2022 and updated most recently in August 25th 2022. 30 individuals will be recruited within a single site for the trial's duration."

Answered by AI
~4 spots leftby Apr 2025